Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
2001 1
2004 4
2005 2
2006 2
2007 2
2008 3
2010 2
2011 1
2012 2
2013 3
2014 2
2015 1
2016 5
2017 3
2018 1
2019 2
2020 5
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis.
Cellerino M, Boffa G, Lapucci C, Tazza F, Sbragia E, Mancuso E, Bruschi N, Minguzzi S, Ivaldi F, Poirè I, Laroni A, Mancardi G, Capello E, Uccelli A, Novi G, Inglese M. Cellerino M, et al. Among authors: ivaldi f. Neurotherapeutics. 2021 Oct;18(4):2579-2588. doi: 10.1007/s13311-021-01104-8. Epub 2021 Sep 22. Neurotherapeutics. 2021. PMID: 34553320 Free PMC article.
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19.
Righi E, Mirandola M, Mazzaferri F, Razzaboni E, Zaffagnini A, Erbogasto A, Vecchia ID, Auerbach N, Ivaldi F, Mongardi M, Minuz P, Milella M, Mehrabi S, Olivieri O, Girelli D, Polati E, Micheletto C, Tacconelli E. Righi E, et al. Among authors: ivaldi f. Infect Dis Ther. 2021 Sep;10(3):1579-1590. doi: 10.1007/s40121-021-00461-3. Epub 2021 Jun 21. Infect Dis Ther. 2021. PMID: 34152573 Free PMC article.
High throughput T epitope mapping and vaccine development.
Li Pira G, Ivaldi F, Moretti P, Manca F. Li Pira G, et al. Among authors: ivaldi f. J Biomed Biotechnol. 2010;2010:325720. doi: 10.1155/2010/325720. Epub 2010 Jun 15. J Biomed Biotechnol. 2010. PMID: 20617148 Free PMC article. Review.
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study.
Cellerino M, Ivaldi F, Pardini M, Rotta G, Vila G, Bäcker-Koduah P, Berge T, Laroni A, Lapucci C, Novi G, Boffa G, Sbragia E, Palmeri S, Asseyer S, Høgestøl E, Campi C, Piana M, Inglese M, Paul F, Harbo HF, Villoslada P, Kerlero de Rosbo N, Uccelli A. Cellerino M, et al. Among authors: ivaldi f. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 5;7(3):e693. doi: 10.1212/NXI.0000000000000693. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32139439 Free PMC article.
Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS.
Bäcker-Koduah P, Infante-Duarte C, Ivaldi F, Uccelli A, Bellmann-Strobl J, Wernecke KD, Sy M, Demetriou M, Dörr J, Paul F, Ulrich Brandt A. Bäcker-Koduah P, et al. Among authors: ivaldi f. Ann Clin Transl Neurol. 2020 Sep;7(9):1628-1641. doi: 10.1002/acn3.51148. Epub 2020 Aug 23. Ann Clin Transl Neurol. 2020. PMID: 32830462 Free PMC article. Clinical Trial.
Teriflunomide treatment reduces B cells in patients with MS.
Gandoglia I, Ivaldi F, Laroni A, Benvenuto F, Solaro C, Mancardi G, Kerlero de Rosbo N, Uccelli A. Gandoglia I, et al. Among authors: ivaldi f. Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e403. doi: 10.1212/NXI.0000000000000403. eCollection 2017 Nov. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 29082295 Free PMC article.
45 results